Literature DB >> 8652635

Alterations in the physiochemical characteristics of low and high density lipoproteins after lipolysis with phospholipase A2. A spin-label study.

I N Gorshkova1, M Menschikowski, W Jaross.   

Abstract

Human low and high density lipoproteins (LDL and HDL, respectively) were treated with porcine pancreatic phospholipase A2 (PLA2) in the presence of albumin resulting in hydrolysis of 40-84% of the lipoproteins phospholipids. The resulting PLA2-treated LDL and HDL and concurrent control lipoproteins incubated without PLA2 were reisolated by ultracentrifugation and labelled with 5-doxyl- and 16-doxyl-stearic acid, and with a spin-labelled analogue of maleimide. Analysis of ESR spectra showed that phospholipid hydrolysis both of LDL and HDL resulted in an increase in order, micro-viscosity and polarity of lipid regions in the surface monolayer of the particles. In the temperature range from 3 degrees C to 50-60 degrees C, Arrhenius plots of a spectral parameter of LDL and HDL labelled with 5-doxyl-stearate exhibited alterations which suggest an increase in free cholesterol content near the surface of the lipoproteins after PLA2-treatment. ESR spectra of the maleimide analogue bound covalently to the protein moiety of the lipoproteins have demonstrated that, following phospholipid hydrolysis, the conformation of the apoproteins became more condensed, with more masked domains. The possible implications of the revealed alterations for enhanced delivery of LDL and HDL cholesterol to cells after phospholipolysis of the lipoproteins are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652635     DOI: 10.1016/0005-2760(95)00237-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Enhanced binding of apolipoprotein A-I variants associated with hypertriglyceridemia to triglyceride-rich particles.

Authors:  Irina N Gorshkova; David Atkinson
Journal:  Biochemistry       Date:  2011-02-20       Impact factor: 3.162

2.  Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia.

Authors:  Irina N Gorshkova; David Atkinson
Journal:  JSM Atheroscler       Date:  2017-02-13

3.  LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein.

Authors:  Liana Asatryan; Ryan T Hamilton; J Mario Isas; Juliana Hwang; Rakez Kayed; Alex Sevanian
Journal:  J Lipid Res       Date:  2004-10-16       Impact factor: 5.922

4.  VLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.

Authors:  Sarada D Tetali; Madhu S Budamagunta; Catalina Simion; Laura J den Hartigh; Tamás Kálai; Kálmán Hideg; Danny M Hatters; Karl H Weisgraber; John C Voss; John C Rutledge
Journal:  J Lipid Res       Date:  2009-12-03       Impact factor: 5.922

Review 5.  Secretory phospholipase A2: a multifaceted family of proatherogenic enzymes.

Authors:  Robert S Rosenson; Michael H Gelb
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

6.  Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.

Authors:  Rolf Eckey; Mario Menschikowski; Peter Lattke; Werner Jaross
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

7.  Binding of human apoA-I[K107del] variant to TG-rich particles: implications for mechanisms underlying hypertriglyceridemia.

Authors:  Irina N Gorshkova; Xiaohu Mei; David Atkinson
Journal:  J Lipid Res       Date:  2014-06-11       Impact factor: 5.922

8.  Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages.

Authors:  Ling Liang; Qiang Xie; Changqing Sun; Yuanhui Wu; Wei Zhang; Weihua Li
Journal:  J Transl Med       Date:  2021-11-27       Impact factor: 5.531

9.  On the present and future role of Lp-PLA2 in atherosclerosis-related cardiovascular risk prediction and management.

Authors:  Zlatko Fras; Jure Tršan; Maciej Banach
Journal:  Arch Med Sci       Date:  2020-08-20       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.